Aura Biosciences
Aura Biosciences is a Cambridge-based biotechnology company that is revolutionizing cancer treatment through its targeted oncology platform. With a focus on ocular and urologic oncology, Aura Biosciences is developing Virus-Like Drug Conjugates (VDCs) that can effectively target a wide range of solid tumors, offering a potential new standard of care for patients.
Choroidal melanoma, a rare and life-threatening ocular cancer, is one of the primary areas of focus for Aura Biosciences. Currently, there are no approved drug therapies for this condition, and the standard treatment using radiotherapy often leads to vision loss and other complications. Aura Biosciences aims to provide early treatment interventions that preserve vision and improve long-term prognosis for patients.
Generated from the website
Also at this address
You might also like
Partial Data by Foursquare.